Agenus Inc. (NASDAQ:AGEN)‘s price-to-sales ratio of 9.18 is creating a long-term opportunity in the value in its stock. The broad Biotechnology industry has an average P/S ratio of 47.58, which is significantly worse than the sector’s 10.93. In the past 13-year record, this ratio went down as low as 4.6 and as high as 56.28. Also, it is up from 53% of the total 726 rivals across the globe.

AGEN traded at an unexpectedly high level on 03/14/2019 when the stock experienced a 1.01% gain to a closing price of $2.99. The company saw 2.58 million shares trade hands over the course of the day. Given that its average daily volume over the 5 sessions has been 2.24 million shares a day, this signifies a pretty significant change over the norm.

Agenus Inc. (AGEN) Analyst Gushes

Analysts are speculating a 134.11% move, based on the high target price ($7) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $7 price target, but the stock is already up 94.16% from its recent lows. However, the stock is trading at -50.33% versus recent highs ($6.02). Analysts believe that we could see stock price minimum in the $7 range (lowest target price), allowing for another 134.11% jump from its current position. Leading up to this report, we have seen a -16.25% fall in the stock price over the last 30 days and a 14.12% increase over the past 3 months. Overall, the share price is up 25.63% so far this year. Additionally, the stock had a day price range of $2.764 to $3.04.

Agenus Inc. (AGEN) Price Potential

Heading into the stock price potential, Agenus Inc. needs to grow just 134.11% to cross its median price target of $7. In order to determine directional movement, the 50-day and 200-day moving averages for Agenus Inc. (NASDAQ:AGEN) are $3.2206 and $2.5082. Given that liquidity is king in the short-term, AGEN is a stock with 127.19 million shares outstanding that normally trades 10.54% of its float. The stock price recently experienced a 5-day gain of 5.65% with 0.21 average true range (ATR). AGEN has a beta of 2.09 and RSI is 48.5.

Investors also need to beware of the Weyerhaeuser Company (NYSE:WY) valuations. The stock trades on a P/S of 2.6, which suggests that the shares are attractive compared with peers. The broad Lumber, Wood Production industry has an average P/S ratio of 9.17, which is significantly better than the sector’s 10.69. In the past 13-year record, this ratio went down as low as 0.56 and as high as 3.98. Also, it is down from 88% of the total 324 rivals across the globe.

Weyerhaeuser Company (WY)’s Lead Over its Technicals

Weyerhaeuser Company by far traveled 24.51% versus a 1-year low price of $20.52. The share price was last seen -2.03% lower, reaching at $25.55 on Mar. 14, 2019. At recent session, the prices were hovering between $25.43 and $26.16. This company shares are 16.36% off its target price of $29.73 and the current market capitalization stands at $19.13B. The recent change has given its price a 2.23% lead over SMA 50 and -33.45% deficit over its 52-week high. The stock witnessed 0.87% gains, 1.83% gains and -25.07% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found WY’s volatility during a week at 2.18% and during a month it has been found around 2.12%.

Weyerhaeuser Company (NYSE:WY) Intraday Metrics

Weyerhaeuser Company (WY) exchanged hands at an unexpectedly low level of 4.1 million shares over the course of the day. Noting its average daily volume at 5.92 million shares each day over the month, this signifies a pretty significant change over the norm.

Weyerhaeuser Company Target Levels

The market experts are predicting a 33.07% rally, based on the high target price of $34 for Weyerhaeuser Company shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $25 range (lowest target price). If faced, it would be a -2.15% drop from its current position. Overall, the share price is up 16.88% year to date [T2].